Skip to main content

Aurinia Pharm Ord(AUPH-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Aurinia Pharm Ord

14315 - 118 AVENUE SUITE 140
EDMONTON A0 T5L 4S6 CAN
P: 250-744-2487
F: 604-369-4115
http://www.auriniapharma.com

Profile

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Key Executives

NameTitle
Information not available.